MYMD PHARMACEUTICALS INC (MYMD)
US62856X2018 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 18.62M | 520.00K | |||
| Cash Equivalents | 300.00K | 750.00K | 560.00K | N/A | N/A | |||
| Marketable Securities | 8.17M | 4.09M | 11.00M | 16.72M | 9.16M | |||
| Receivables | N/A | N/A | N/A | 1.20M | 40.00K | |||
| Inventories | N/A | N/A | N/A | N/A | 200.00K | |||
| Other Current Assets | 1.26M | 570.00K | 1.11M | 300.00K | 390.00K | |||
| Total Current Assets | 9.74M | 5.40M | 12.67M | 36.84M | 10.31M | |||
| Non-Current Assets | ||||||||
| PPE Net | 90.00K | 140.00K | 150.00K | N/A | 30.00K | |||
| Investments And Advances | 1.50M | 1.50M | 1.50M | N/A | N/A | |||
| Goodwill | 10.50M | 10.50M | 10.50M | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | 170.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 370.00K | |||
| Total Non-Current Assets | 12.09M | 12.14M | 12.14M | 0.00 | 570.00K | |||
| TOTAL ASSETS | 21.83M | 17.54M | 24.81M | 36.84M | 10.88M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | N/A | N/A | |||
| Accrued Expenses | 760.00K | 380.00K | 170.00K | N/A | 870.00K | |||
| Accounts Payable | 1.35M | 2.36M | 870.00K | 2.20M | 660.00K | |||
| Other Current Liabilities | 3.59M | 30.00K | 0.00 | 60.00K | N/A | |||
| Total Current Liabilities | 5.70M | 2.77M | 1.04M | 2.26M | 1.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.00K | 80.00K | 130.00K | N/A | N/A | |||
| Total Non-Current Liabilities | 20.00K | 70.00K | 130.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 5.72M | 2.84M | 1.17M | 2.26M | 1.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -97.09M | -93.76M | -78.56M | -137.16M | -119.58M | |||
| Common Shares | 113.19M | 108.45M | 102.20M | 171.74M | 128.92M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Shares Outstanding | 47.00M | 39.47M | 37.67M | 8.79M | 870.00K | |||
| Tangible Book Value per Share | 0.10 | 0.10 | 0.35 | 3.92 | 10.56 | |||
| Total Shareholders' Equity | 16.11M | 14.70M | 23.65M | 34.58M | 9.36M | |||
| TOTAL LIABILITIES AND EQUITY | 21.83M | 17.54M | 24.81M | 36.84M | 10.88M | |||
| Statistics | ||||||||
| Current Ratio | 1.71 | 1.95 | 12.18 | 16.30 | 6.74 | |||
| Return On Assets (ROA) | -32.43% | -86.66% | -120.48% | -47.72% | -35.75% | |||
| Return On Equity (ROE) | -43.95% | -103.40% | -126.38% | -50.84% | -41.56% | |||
All data in USD